Update on antibacterial and antifungal drugs – can we master the resistance crisis?
- 31 October 2011
- journal article
- editorial
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 11 (5) , 429-432
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Optimizing dosage to prevent emergence of resistance – lessons from in vitro modelsCurrent Opinion in Pharmacology, 2011
- At least it won’t hurt: the personal risks of antibiotic exposureCurrent Opinion in Pharmacology, 2011
- Beyond serial passages: new methods for predicting the emergence of resistance to novel antibioticsCurrent Opinion in Pharmacology, 2011
- Dosing of colistin—back to basic PK/PDCurrent Opinion in Pharmacology, 2011
- A new evolutionary and pharmacokinetic–pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugsCurrent Opinion in Pharmacology, 2011
- Resistance drives antibacterial drug developmentCurrent Opinion in Pharmacology, 2011
- Analysis of the Resistome of a Multidrug-Resistant NDM-1-Producing Escherichia coli Strain by High-Throughput Genome SequencingAntimicrobial Agents and Chemotherapy, 2011
- The 2010 Garrod Lecture: The dimensions of evolution in antibiotic resistance: ex unibus plurum et ex pluribus unumJournal of Antimicrobial Chemotherapy, 2011
- Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspectiveDrug Resistance Updates, 2011
- The global need for effective antibiotics—A summary of plenary presentationsDrug Resistance Updates, 2011